Filing Details

Accession Number:
0000886163-14-000034
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-20 18:40:19
Reporting Period:
2014-03-18
Filing Date:
2014-03-20
Accepted Time:
2014-03-20 18:40:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216074 L John Lamattina 11119 North Torrey Pines Road, Suite 200
La Jolla CA 92037
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-18 5,000 $8.97 26,356 No 4 M Direct
Common Stock Disposition 2014-03-18 5,000 $78.83 21,356 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-03-18 5,000 $0.00 5,000 $8.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-02-07 No 4 M Direct
Footnotes
  1. The option becomes exercisable in 36 successive equal monthly installments upon completion of each calendar month of service beginning on the grant date.